CommentaryTubal contraception and ovarian cancer risk: a global view☆,☆☆
Section snippets
Acknowledgments
The views expressed in this commentary do not necessarily reflect those of FHI 360, Virginia Commonwealth University, Brigham and Women's Hospital, Harvard University or the funding agencies.
References (34)
- et al.
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm
Hum Pathol
(2011) - et al.
"Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer
Gynecol Oncol
(2011) - et al.
Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies
Fertil Steril
(2014) - et al.
Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: A meta-analysis
Eur J Cancer
(2016) - et al.
Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere
Gynecol Oncol
(2013) - et al.
Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial
Fertil Steril
(2013) - et al.
Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention
Am J Obstet Gynecol
(2014) - et al.
Characterization of tubal occlusion after transcervical polidocanol foam (PF) infusion in baboons
Contraception
(2015) - et al.
Blockade of tubal patency following transcervical administration of polidocanol foam: initial studies in rhesus macaques
Contraception
(2014) - et al.
Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group
Lancet
(2016)
Ovarian Cancers: Evolving Paradigms in Research and Care
(2016)
Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship
Am J Surg Pathol
(2007)
The role of the fallopian tube in ovarian cancer
Clin Adv Hematol Oncol
(2012)
The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer
Endocr Relat Cancer
(2011)
Pelvic inflammatory disease and the risk of epithelial ovarian cancer
Cancer Epidemiol Biomarkers Prev
(1995)
Salpingitis, salpingoliths, and serous tumors of the ovaries: is there a connection?
Int J Gynecol Pathol
(2002)
Possible role of ovarian epithelial inflammation in ovarian cancer
J Natl Cancer Inst
(1999)
Cited by (4)
Intrauterine device use and risk of ovarian cancer: Results from the New England Case-Control study and Nurses' Health Studies
2021, International Journal of CancerWhat are the mechanisms of action of the different contraceptive methods to reduce the risk of ovarian cancer?
2021, European Journal of Contraception and Reproductive Health CareContraception options for patients with known hereditary risk for ovarian cancer
2019, Journal of the American Academy of Physician AssistantsCurrent Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research
2017, Journal of the National Cancer Institute
- ☆
Funding: RLC and GSK are supported by grants from the Bill & Melinda Gates Foundation and a cooperative agreement from the United States Agency for International Development (USAID).
- ☆☆
Conflicts of Interest: None.
© 2016 Elsevier Inc. All rights reserved.